NAD+ 200mg/ml — Class II drug recall D-1106-2023
Terminated recall by TMC Acquisitions LLC dba Tailor Made Compounding, reported 2023-08-30, distributed nationwide. Lack of Assurance of Sterility
| Recall number | D-1106-2023 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | TMC Acquisitions LLC dba Tailor Made Compounding, Nicholasville, KY, United States |
| Recall initiated | 2023-08-15 |
| Classified | 2023-08-24 |
| Reported by FDA | 2023-08-30 |
| Terminated | 2024-09-30 |
| Distributed | Nationwide (US) |
| Quantity | 99 vials |
| Reason classes | sterility |
| Lot numbers | 07192307A2 |
| Expiration dates | 2023-11-18 |
Product
NAD+ 200mg/ml, 10ml vials, Tailor Made Compounding.
Reason for recall
Lack of Assurance of Sterility
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1106-2023. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.